Page last updated: 2024-09-05

sb 203580 and dimethylarginine

sb 203580 has been researched along with dimethylarginine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(dimethylarginine)
Trials
(dimethylarginine)
Recent Studies (post-2010) (dimethylarginine)
3,48941,13751953244

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, YX; Jian, D; Li, J; Li, WZ; Shi, W; Wang, B; Xie, HF1

Other Studies

1 other study(ies) available for sb 203580 and dimethylarginine

ArticleYear
Asymmetrical dimethylarginine promotes the senescence of human skin fibroblasts via the activation of a reactive oxygen species-p38 MAPK-microRNA-138 pathway.
    Journal of dermatological science, 2015, Volume: 78, Issue:2

    Topics: Acetylcysteine; Arginine; Back; Cells, Cultured; Cellular Senescence; Child; Enzyme Inhibitors; Face; Fibroblasts; Free Radical Scavengers; Humans; Imidazoles; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Pyridines; Reactive Oxygen Species; Skin; Skin Aging; Ultraviolet Rays

2015